There is no doubting the impact that 2020 has had on our industry, our country, and our world. With more than 700 therapeutics in the pipeline for COVID-19 alone, speed-to-clinic is a top priority for early-phase manufacturers. There are myriad considerations when transitioning from the lab to clinical operations, specifically for emerging industries such as […]
